Identification of molecular signatures associated with sleep disorder and Alzheimer’s disease

Abstract

BackgroundAlzheimer’s disease (AD) and sleep disorders are both neurodegenerative conditions characterized by impaired or absent sleep. However, potential common pathogenetic mechanisms of these diseases are not well characterized.MethodsDifferentially expressed genes (DEGs) were identified using publicly available human gene expression profiles GSE5281 for AD and GSE40562 for sleep disorder. DEGs common to the two datasets were used for enrichment analysis, and we performed multi-scale embedded gene co-expression network analysis (MEGENA) for common DEGs. Fast gene set enrichment analysis (fGSEA) was used to obtain common pathways, while gene set variation analysis (GSVA) was applied to quantify those pathways. Subsequently, we extracted the common genes between module genes identified by MEGENA and genes of the common pathways, and we constructed protein-protein interaction (PPI) networks. The top 10 genes with the highest degree of connectivity were classified as hub genes. Common genes were used to perform Metascape enrichment analysis for functional enrichment. Furthermore, we quantified infiltrating immune cells in patients with AD or sleep disorder and in controls.ResultsDEGs common to the two disorders were involved in the citrate cycle and the HIF-1 signaling pathway, and several common DEGs were related to signaling pathways regulating the pluripotency of stem cells, as well as 10 other pathways. Using MEGENA, we identified 29 modules and 1,498 module genes in GSE5281, and 55 modules and 1,791 module genes in GSE40562. Hub genes involved in AD and sleep disorder were ATP5A1, ATP5B, COX5A, GAPDH, NDUFA9, NDUFS3, NDUFV2, SOD1, UQCRC1, and UQCRC2. Plasmacytoid dendritic cells and T helper 17 cells had the most extensive infiltration in both AD and sleep disorder.ConclusionAD pathology and pathways of neurodegeneration participate in processes contributing in AD and sleep disorder. Hub genes may be worth exploring as potential candidates for targeted therapy of AD and sleep disorder.

Exploration of novel biomarkers in Alzheimer’s disease based on four diagnostic models

“…DCs play specific roles in the immune microenvironment during processes such as aging and in AD ( Mrdjen et al, 2018 ). pDCs showed markedly extensive infiltration in AD ( Liang et al, 2022 ). Furthermore, naive B cells and M2 macrophages found a high infiltrated degree in patients with AD when we used the CIBERSORT method.…”

Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of Differentially Expressed Genes

“…Additionally, while no studies directly related to ALS were discovered, other studies related to other neurological diseases were found in the cases of the EEF1A1 [ 49 ], COX5A [ 50 ] and RPL12 and RPL15 genes [ 51 ].…”

Identification of novel hub genes for Alzheimer’s disease associated with the hippocampus using WGCNA and differential gene analysis

“…In the past literature, there is the identification of AD-related hub genes by using only the modular genes in DEGs or WGCNA to identify AD hub genes, which is still slightly insufficient in terms of in data selection and processing ( Wu et al, 2021 ; Liang et al, 2022 ). In comparison, the strengths in our study: 1.…”